Correlation Between Precision BioSciences and Design Therapeutics
Can any of the company-specific risk be diversified away by investing in both Precision BioSciences and Design Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Precision BioSciences and Design Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Precision BioSciences and Design Therapeutics, you can compare the effects of market volatilities on Precision BioSciences and Design Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Precision BioSciences with a short position of Design Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Precision BioSciences and Design Therapeutics.
Diversification Opportunities for Precision BioSciences and Design Therapeutics
-0.58 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Precision and Design is -0.58. Overlapping area represents the amount of risk that can be diversified away by holding Precision BioSciences and Design Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Design Therapeutics and Precision BioSciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Precision BioSciences are associated (or correlated) with Design Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Design Therapeutics has no effect on the direction of Precision BioSciences i.e., Precision BioSciences and Design Therapeutics go up and down completely randomly.
Pair Corralation between Precision BioSciences and Design Therapeutics
Given the investment horizon of 90 days Precision BioSciences is expected to under-perform the Design Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Precision BioSciences is 1.15 times less risky than Design Therapeutics. The stock trades about -0.07 of its potential returns per unit of risk. The Design Therapeutics is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest 950.00 in Design Therapeutics on September 25, 2024 and sell it today you would lose (324.00) from holding Design Therapeutics or give up 34.11% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Precision BioSciences vs. Design Therapeutics
Performance |
Timeline |
Precision BioSciences |
Design Therapeutics |
Precision BioSciences and Design Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Precision BioSciences and Design Therapeutics
The main advantage of trading using opposite Precision BioSciences and Design Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Precision BioSciences position performs unexpectedly, Design Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Design Therapeutics will offset losses from the drop in Design Therapeutics' long position.Precision BioSciences vs. Fate Therapeutics | Precision BioSciences vs. Caribou Biosciences | Precision BioSciences vs. Arcus Biosciences | Precision BioSciences vs. Karyopharm Therapeutics |
Design Therapeutics vs. Fate Therapeutics | Design Therapeutics vs. Caribou Biosciences | Design Therapeutics vs. Arcus Biosciences | Design Therapeutics vs. Karyopharm Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Other Complementary Tools
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |